Craft

Labcorp

Stock Price

$203.9

2024-07-03

Market Capitalization

$17.1 B

2024-07-01

Revenue

$12.2 B

FY, 2023

Labcorp Summary

Company Summary

Overview
Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions. It operates through two segments: Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The company offers pharmaceutical development, medical device and diagnostic development, crop protection product testing, chemical product testing, and other services.
Type
Public
Status
Active
Founded
1995
HQ
Burlington, NC, US | view all locations
Website
https://www.labcorp.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Adam H. Schechter

    Adam H. Schechter, Chairman, President and CEO

  • Lance V. Berberian

    Lance V. Berberian, Executive Vice President and Chief Information and Technology Officer

  • Glenn A. Eisenberg

    Glenn A. Eisenberg, Executive Vice President and Chief Financial Officer

  • Brian J. Caveney

    Brian J. Caveney, EVP and President, Early Development Research Laboratories and Chief Medical and Scientific Officer

Operating MetricsView all

Countries (Customers)

100

FY, 2021

Patient Encounters per Week

3M

FY, 2021

Patient Encounters per Year

160M

FY, 2021

LocationsView all

2 locations detected

  • Burlington, NC HQ

    United States

    531 S Spring St

  • Burlington, NC

    United States

    358 S Main St

Labcorp Financials

Summary Financials

Revenue (Q1, 2024)
$3.2B
Gross profit (Q1, 2024)
$897.3M
Net income (Q1, 2024)
$228.3M
Cash (Q1, 2024)
$99.3M
EBIT (Q1, 2024)
$321.3M
Enterprise value
$5.9B

Footer menu